Ultrasound is often used to further evaluate suspicious breast lesions found by mammography. But its results are not always reliable enough to avoid a biopsy, in which some of the breast tissue is surgically removed and examined.
"Only 10 to 15 percent of women who undergo a breast biopsy actually have a malignant tumour, leading many women to experience unnecessary anxiety, discomfort and expense," said the study's lead author, Quing Zhu, Ph.D., associate professor of electrical and computer engineering at the University of Connecticut in Storrs.
By combining ultrasound with optical tomography, which employs diffused light in the near infrared (NIR) spectrum, the researchers were able to calculate the concentration of haemoglobin and microvessels present in each lesion. A high density of microvessels in a tumour is known to be highly correlated with malignancy.
"We found that early-stage invasive cancers have a two-fold higher total haemoglobin concentration compared with benign lesions," Dr. Zhu said. "These findings demonstrate that this technique has great potential for non-invasively distinguishing malignant and benign masses to reduce benign biopsies."
In the study, 65 patients with a total of 81 breast lesions were examined with ultrasound and optical tomography. Breast lesions were then biopsied. The biopsy results confirmed eight invasive cancers and 73 benign lesions. The average total hemoglobin concentration within the malignant group was more than twice that of benign group.
To perform the dual imaging exam, engineers in Dr. Zhu's lab added NIR sensors to an ultrasound transducer, creating a hand-held probe capable of acquiring both ultrasound images and light waves. The collected images and optical data were then processed using a computer algorithm.
MEDICA.de; Source: Radiological Society of North America